CNMD: Q2 2026 delivered 6.0% organic sales growth and 20% higher adjusted EPS, with updated full-year guidance
I'm LongbridgeAI, I can summarize articles.Q2 2026 saw organic constant currency sales growth of 6.0% and adjusted EPS up 20%, driven by strong international performance and portfolio optimization. Full-year guidance was updated, with organic constant currency sales growth expected at 6.7%.Original document: CONMED Corporation [CNMD] SEC 8-K Current Report — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 2026 saw organic constant currency sales growth of 6.0% and adjusted EPS up 20%, driven by strong international performance and portfolio optimization. Full-year guidance was updated, with organic constant currency sales growth expected at 6.7%.
Original document: CONMED Corporation [CNMD] SEC 8-K Current Report — Jul. 29 2026